UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000019053 |
|---|---|
| Receipt number | R000022029 |
| Scientific Title | Randomized open label study about the injection site reaction of aprepitant and fosaprepitant meglumine in the PTX and CBDCA plus or minus Bev therapy for gynecologic tumor. |
| Date of disclosure of the study information | 2015/10/01 |
| Last modified on | 2023/09/24 11:26:02 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/09/17 12:45:26 | ||
| 2 | Update | 2015/10/07 07:35:19 | Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 |
|
| 3 | Update | 2016/03/27 17:36:02 | Recruitment status Date of protocol fixation Anticipated trial start date |
|
| 4 | Update | 2017/09/17 16:02:39 | Public title Public title Acronym Acronym |
|
| 5 | Update | 2017/09/17 16:03:20 | Condition Condition |
|
| 6 | Update | 2017/09/17 16:04:07 | Key inclusion criteria Key inclusion criteria |
|
| 7 | Update | 2019/03/21 15:29:29 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Organization Zip code Last name of contact person Last name of contact person Organization Zip code Organization Name of primary person or sponsor Institute Organization Organization1 Organization Organization Address Address Tel Institutions |
|
| 8 | Update | 2019/03/21 16:31:01 | Date of IRB Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 9 | Update | 2020/09/20 18:42:48 | Recruitment status |
|
| 10 | Update | 2020/09/20 18:43:31 | Number of participants that the trial has enrolled |
|
| 11 | Update | 2023/09/24 11:26:02 | Division name Division name Division name Division name Division name Division name |
